Cell Therapy
Creating Efficiencies in Engineered Cell Therapy Development with Comprehensive Electroporation Support
Sarah Meeks, Ph.D.
MaxCyte
PAO-09-23-CL-09Sep 28, 2023
Bone Regeneration
A Novel Technology Platform for Bone Regeneration and Cancer Treatment
Denis Dufrane, M.D., Ph.D.
PAO-03-23-CL-06Mar 20, 2023
T Cell Expansion Platform
Terumo Blood and Cell Technologies Presents First Quantum® Flex Data for Multiple Size Bioreactors Showing Rapid T Cell Expansion to Numbers Equivalent of a Therapeutic Dose
Terumo Blood and Cell Technologies
PR-M02-23-03Feb 23, 2023
Cell Therapy
Moving from Autologous to Allogeneic Cell Therapies: Drivers and Hurdles
Cynthia A. Challener, Ph.D.
Pharma's Almanac
PAO-01-23-NI-01Jan 31, 2023
Cell Therapy
Bedside Cell Therapies: Point-of-Care Manufacturing Is Slowly Becoming a Reality
Cynthia A. Challener, Ph.D.; David Alvaro, Ph.D.
Pharma's Almanac
PAO-11-022-NI-08Nov 15, 2022
Cell Therapy
A PODular Therapies-as-a-Service Approach To Fundamentally Change the CAR-T Cell Therapy Landscape
David Alvaro, Ph.D.
Pharma's Almanac
PAO-05-022-CL-05May 31, 2022
Phase I Trial
Anixa Biosciences Announces the Initiation of its Ovarian Cancer CAR-T Phase I Trial at Moffitt Cancer Center
Anixa Biosciences
PR-M03-22-17Mar 30, 2022
Cell Therapy
Expanding Access to Cell Therapies with a Patient-Centric Focus
Amy L. Ronneberg
Be The Match BioTherapies
PAO-02-022-CL-12Mar 12, 2022
Cell Therapy
Enabling Novel Cell Therapies by Leveraging Established Blood Stem Cell Transplant Infrastructure
Chris McClain
Be The Match BioTherapies
PAO-09-21-CL-04Sep 09, 2021
Cell Therapy
Economically Viable, Same-Day Autologous Cell Therapies
Gregory Frost, Ph.D.; Sid Kerkar, M.D.
EXUMA Biotechnology
PAO-01-21-CL-06Feb 04, 2021
Cell Therapies
A Personalized Cell Therapy Chain Management Platform
Matthew Lakelin
TrakCel
PAP-Q2-20-CL-032Jul 01, 2020